- Home
- NVCT vs TERN Comparison
NVCT vs TERN Comparison
Compare NVCT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- TERN
- Stock Information
- Founded
- NVCT 2020
- TERN 2017
- Country
- NVCT United States
- TERN United States
- Employees
- NVCT N/A
- TERN N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- NVCT Health Care
- TERN Health Care
- Exchange
- NVCT Nasdaq
- TERN Nasdaq
- Market Cap
- NVCT 249.1M
- TERN 263.8M
- IPO Year
- NVCT 2022
- TERN 2021
- Fundamental
- Price
- NVCT $8.98
- TERN $3.28
- Analyst Decision
- NVCT Strong Buy
- TERN Buy
- Analyst Count
- NVCT 3
- TERN 5
- Target Price
- NVCT $17.00
- TERN $15.63
- AVG Volume (30 Days)
- NVCT 132.1K
- TERN 687.9K
- Earning Date
- NVCT 05-06-2025
- TERN 05-08-2025
- Dividend Yield
- NVCT N/A
- TERN N/A
- EPS Growth
- NVCT N/A
- TERN N/A
- EPS
- NVCT N/A
- TERN N/A
- Revenue
- NVCT N/A
- TERN N/A
- Revenue This Year
- NVCT N/A
- TERN N/A
- Revenue Next Year
- NVCT N/A
- TERN N/A
- P/E Ratio
- NVCT N/A
- TERN N/A
- Revenue Growth
- NVCT N/A
- TERN N/A
- 52 Week Low
- NVCT $4.44
- TERN $1.87
- 52 Week High
- NVCT $11.80
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- NVCT 44.39
- TERN 60.54
- Support Level
- NVCT $9.92
- TERN $3.01
- Resistance Level
- NVCT $11.15
- TERN $3.17
- Average True Range (ATR)
- NVCT 0.64
- TERN 0.18
- MACD
- NVCT -0.09
- TERN 0.02
- Stochastic Oscillator
- NVCT 26.94
- TERN 91.35
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.